Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia

Robert L. Findling, Ronald P. Landbloom, Mary Mackle, Wendi Pallozzi, Sabine Braat, Carla Hundt, Marianne Z. Wamboldt, Maju Mathews

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia'. Together they form a unique fingerprint.

Medicine & Life Sciences